Home
About
About Anagenics
Board of Directors
Divisions
Our Divisions
Beauty
Brands
évolis®
Uspa
Investors
Investor Centre
ASX Announcements
2024
2023
2022
2021
2020
2019
Financial Information & Reports
Share Registry Information
Analyst Coverage
Share Information
Anagenics in the media
Newsletter Archive
Corporate Governance
Corporate Governance
Board Charter
Code of Conduct
Policies
Audit Committee Charter
Nomination and Remuneration Committee Charter
Performance Evaluation Process
Corporate Code of Conduct
Environmental, Social and Governance Statement
✕
2022 ASX Announcements
Home
Investor Centre
ASX Announcements
2022 ASX Announcements
Date
Announcement
30/12/2022
Application for quotation of securities
09/12/2022
Corporate Update and Acquisition
29/11/2022
Amended Constitution
29/11/2022
CEO’s AGM Address
29/11/2022
Final Directors Interest Notice – Eck
29/11/2022
Results of Annual General Meeting
28/10/2022
Notice of Annual General Meeting/Proxy Form
26/10/2022
Appendix 4C and Quarterly Activity Report
17/10/2022
Director Resignation – Dennis Eck
23/09/2022
Annual Report to Shareholders
23/09/2022
Appendix 4G and Corporate Governance Statement
16/09/2022
Change of Director’s Interest Notice – Greasley
25/08/2022
Appendix 4E and FY22 Financial Report
26/07/2022
Advangen Japan Divestment and Earn-Out Agreement
26/07/2022
Appendix 4C and Quarterly Activity Report
08/07/2022
Appointment of Exec Director, Corporate and Trading Update
08/07/2022
Initial Director’s Interest Notice – Greasley
28/04/2022
Appendix 4C and Quarterly Activity Report
16/03/2022
New Leadership Driving Business Transformation
02/03/2022
Notification of cessation of securities – AN1
01/03/2022
Anagenics Appoints CEO
01/03/2022
Final Director’s Interest Notice – Halasz
15/02/2022
Anagenics Board and Leadership Transition
15/02/2022
Appendix 4D and Half Year Report
15/02/2022
Final Director’s Interest Notice – Gordon
15/02/2022
Initial Director’s Interest Notice – Beard
02/02/2022
Change of Director’s Interest Notice – Halasz
28/01/2022
Appendix 4C and Quarterly Activity Report
20/01/2022
Change in substantial holding from HNG
07/01/2022
Application for quotation of securities – AN1
07/01/2022
Change of Director’s Interest Notice – DE
07/01/2022
Cleansing Notice
07/01/2022
Release of Shares from Voluntary Escrow
Let’s get in touch
Got a question? Email us
Please leave this field empty.
Please leave this field empty.
Register for Investor Alerts
I consent to recieving emails about Anagenics products and special offers. By submitting this form you agree to our terms. See our privacy policy to learn about how we use your information.*
Leave this field empty if you're human: